Patients with glaucoma, which affects 60 million people worldwide, can lose up to 40 percent of their sight before they begin to notice any change in vision.

Targeting inflammation to fight cancer is a new approach with a long history.

Pneumonia causes around 2 million child deaths per year globally and the burden is especially heavy in a country like Bangladesh, where a third of the population is aged 14 or below.

Bringing healthcare closer to where people live, work and shop can effectively tackle hypertension – the most deadly noncommunicable disease.

Novartis and Broad Institute researchers explore how gut bacteria contribute to health and disease, beginning with type 1 diabetes.

Scientists are using the imaging technique to see complex molecular structures in stunning detail.

Novartis teams test combinations of targeted therapeutic agents to combat drug resistance in tumors.

Novartis collaborates with Homology Medicines to adapt and refine genome editing technology.

Novartis collaborates with the Banner Alzheimer’s Institute to test treatments for preventing Alzheimer’s disease.

Novartis is developing an experimental drug for weight loss.